Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Prostate Drug Appears Safer Than Thought

Finasteride does not cause more aggressive cancer, study contends


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Ankylosing Spondylitis
Baldness
Basal Cell Carcinoma
More...

Related Healthscout Videos
 border=
Optimistic Healing
Cancer Treatment for Any Size
Fever Kills Cancer
Cancer Detection
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Cialis
Epogen
Flomax
Iressa
More...

Related News Articles
 border=
Low Vitamin D Tied to Estrogen Decline
Caring Through Sharing -- Life Changing Stories
Hormone Therapy & Breast Cancer
Study: High Breast Density Increases Risk for Cancer Recurrence
More...

WEDNESDAY, July 8 (HealthDay News) -- Doctors don't have to be so cautious in prescribing the drug finasteride to men at risk for prostate cancer, a new study suggests.

Physicians face a dilemma when trying to decide whether to use the drug, which has been shown to prevent prostate cancer in about one in five men who take it. However, findings from the Prostate Cancer Prevention Trial published in 2003 concluded that men who developed prostate cancer while taking finasteride were 25 percent more likely to develop an aggressive form of the disease.

Text Continues Below



But a new study from the Stanford University School of Medicine suggests that the drug does not increase the risk for aggressive prostate cancer but simply makes it easier to diagnose. The study appears in the July 7 issue of Clinical Cancer Research.

The Stanford team suspected a flaw in the analysis of data in the 2003 study, rather than a problem with the drug. To test this theory, they analyzed data on 1,304 men who'd had an abnormal digital rectal exam or high PSA test results and had been referred to Stanford. None of the men was taking finasteride. Prostate cancer was eventually diagnosed in nearly 500 of the men, including 247 who had aggressive, high-grade cancer.

Finasteride shrinks the prostate, making malignancies easier to detect, the researchers said. And the smaller the prostate, the more likely a biopsy would yield a diagnosis of high-grade cancer, they said, and the more likely a high PSA level would predict the disease. For example, the diagnostic rate for one level of high-grade cancer was 29.7 percent in men with prostates between 20 to 29.9 cubic centimeters, compared with 6.5 percent for men with prostates larger than 80 cubic centimeters.

"We're showing that this is all related to size" of the prostate, Dr. Joseph Presti Jr., a research professor in urology and director of the urologic oncology program at Stanford, said in a news release from the university.

Page:  1 | 2 | Next >>

-- Robert Preidt

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 7/8/2009

Related Links
 border=
From Healthscout's partner site on prostate, ProstateCommons.com
Prostate Check: Test yourself for symptoms online
Video: Prostate ultrasounds may save lives
Treatment: Get information about enlarged prostate treatments





SOURCE: Stanford Medicine, news release, July 7, 2009


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service    
Advertising Policy